Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577703
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-09-16
Brief Title:
First-In-Human Phase I Trial of Ningetinib CT053PTSA in the Patients With Advanced Solid Tumors
Sponsor:
Sunshine Lake Pharma Co Ltd
Organization:
Sunshine Lake Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-08
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-16
First Submit QC Date:
September 30 2020
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-30
Last Update Post Date:
2020-10-08
Last Update Post Date Type:
ACTUAL